8th January 2021 Product update: rapidvirology staff writer
CE-Marked COVID-19 Rapid Antigen Test Detects Fast-Spreading Variant
JOYSBIO (Tianjin) Biotechnology has announced its SARS-CoV-2 Antigen Rapid Test Kit can detect the new coronavirus strain, referred to as SARS-CoV-2 VUI 202012/01, Variant of Concern 202012/01, VOC-202012/01, or lineage B.1.1.7.
The strain was identified in England last fall and is said to cause the spikes seen in the UK and Ireland. It has also appeared in France as well as the United States.
SARS-CoV-2 VUI 202012/01 is believed to be a more contagious strain than other variants of COVID-19. As a result, many nations have restricted travel from the United Kingdom as the world continues to grapple with a disease that has caused more than 84 million cases and close to 2 million deaths.
The SARS-CoV-2 Antigen Rapid Test Kit from JOYSBIO produces accurate results in as little as 15 minutes. The test, designed to be as easy to administer as a saliva test, uses a small nasal swab inserted approximately 2.5 centimetres into the nostril. The smaller swab is far less invasive than, the longer nasopharyngeal (NP) swab used in most COVID-19 tests worldwide.
JOYSBIO's revolutionary test kit relies on a lateral flow immunoassay for the qualitative detection of COVID-19 antigens in upper respiratory samples during the acute phase of infection. This style of test is widely used internationally for rapid coronavirus screening and diagnosis. The test was clinically evaluated to prove its efficacy.
"We are pleased to report that our popular antigen test is effective at identifying the concerning new strain of COVID-19," said company spokesperson Rick Zhang. "We hope our kit brings reassurance and hope that we will soon be able to move beyond our lengthy battle against COVID-19."
JOYSBIO's COVID-19 Rapid Antigen Test Kit is CE-IVD marked. JOYSBIO is currently applying for WHO Emergency Use Listing (EUL) and US FDA Emergency Use Authorization (EUA)
JOYSBIO is an ISO 13485 - Medical Devices certified manufacturer.
For more information please use the 'Request Information' button provided below.
Date Published: 8th January 2021
Source article link: View
Note: This content has been edited by a rapidvirology.com staff writer for style and content.
Manufacturer Confirms No Impact on